abstract A defining property of L-type Ca 2 ϩ channels is their potentiation by both 1,4-dihydropyridine agonists and strong depolarization. In contrast, non-L-type channels are potentiated by neither agonist nor depolarization, suggesting that these two processes may by linked. In this study, we have tested whether the mechanisms of agonist-and depolarization-induced potentiation in the cardiac L-type channel ( ␣ 1C ) are linked. We found that the mutant L-type channel GFP-␣ 1C (TQ → YM), bearing the mutations T1066Y and Q1070M, was able to undergo depolarization-induced potentiation but not potentiation by agonist. Conversely, the chimeric channel GFP-CACC was potentiated by agonist but not by strong depolarization. These data indicate that the mechanisms of agonistand depolarization-induced potentiation of ␣ 1C are distinct. Since neither GFP-CACC nor GFP-CCAA was potentiated significantly by depolarization, no single repeat of ␣ 1C appears to be responsible for depolarization-induced potentiation. Surprisingly, GFP-CACC displayed a low estimated open probability similar to that of the ␣ 1C , but could not support depolarization-induced potentiation, demonstrating that a relatively low open probability alone is not sufficient for depolarization-induced potentiation to occur. Thus, depolarization-induced potentiation may be a global channel property requiring participation from all four homologous repeats.
I N T R O D U C T I O N
Voltage-gated Ca 2 ϩ channels respond to membrane depolarization by allowing Ca 2 ϩ into the cell, and, thus, mediate a variety of cellular responses in neurons and muscle, including transmitter release, neurite outgrowth, altered gene expression, exocytosis, and muscle contraction (Reuter, 1983; Hoshi and Smith, 1987; Tsien et al., 1988; Tanabe et al., 1993) . Thus, modification of Ca 2 ϩ influx provides an important mechanism for the regulation of many downstream Ca 2 ϩ -dependent responses. One source of modification is potentiation, whereby a channel is stabilized in the open state, and intracellular Ca 2 ϩ levels are increased as a result.
L-type Ca 2 ϩ channels show a shift in gating mode in response to either strong depolarization or 1,4-dihydropyridine (DHP)* agonist. After strong depolarization, the channel enters a state of higher open probability (P o ) and long open times that can be detected by a number of different pulse paradigms. For example, after a strong, conditioning depolarization (e.g., ϩ 120 mV) followed by a 50-150-ms return to the holding potential, a subsequent, moderate depolarization elicits a Ca 2 ϩ channel current that is about twofold larger than that measured without the conditioning depolarization (Bourinet et al., 1994; Cens et al., 1996 Cens et al., , 1998 . This effect, which implies an alteration of gating that persists after channel closing, will be designated "depolarization-induced facilitation." Both L-and non-L-type channels are also able to undergo another form of prepulse facilitation ("Ca 2 ϩ /CAM-dependent facilitation"; Lee et al., 2000; Zühlke et al., 2000; DeMaria et al., 2001) , which differs from depolarization-induced facilitation in that it has a bell-shaped dependence on the prepulse potential that arises from a primary dependence upon Ca 2 ϩ entry. Ca 2 ϩ /CAM-dependent facilitation appears to depend specifically (Lee et al., 2000) upon the ␤ 2a subunit, and does not occur in cells expressing ␤ 1 , the isoform present in the dysgenic myotubes used in our study. Unlike Ca 2 ϩ /CAM-dependent facilitation, depolarization-induced facilitation may be related to another form of altered gating observed when a strong depolarization is followed immediately by repolarization to an intermediate potential (Hoshi and Smith, 1987; Pietrobon and Hess, 1990; Kleppisch et al., 1994) . This phenomenon, referred to here as de-496 Distinct Mechanisms of Potentiation polarization-induced potentiation, results in a mode of gating characterized at the single-channel level by high P o and long open times, which is also referred to as "mode 2" gating (Pietrobon and Hess, 1990) . As an indication of depolarization-induced entry into mode 2, we have measured whole-cell tail currents upon repolarization to Ϫ 50 mV immediately after a strong, conditioning depolarization. With this protocol, high P o and long open times are reflected by an increased tail-current amplitude and slower rate of tail-current decay, respectively. Mode 2 gating of L-type channels is also promoted by DHP agonists (Hess et al., 1984; Nowycky et al., 1985; Hoshi and Smith, 1987) . Given the similarities between agonist-and depolarization-induced potentiation, it is important to know the degree to which the two processes are related.
The cardiac L-type channel, ␣ 1C , normally exhibits a low P o Ͻ 0.05 (Cachelin et al., 1983; Lew et al., 1991) and can be potentiated by both strong depolarization and DHP agonists. By contrast, the neuronal non-L-type channel, ␣ 1A , exhibits a high P o of ‫ف‬ 0.6 (Llinas et al., 1989) and lacks both depolarization-induced facilitation (Bourinet et al., 1994) , and DHP-induced potentiation . These observations suggest the possibility that depolarization-and agonistinduced potentiation can only occur in channels like ␣ 1C that have an intrinsically low P o .
In an attempt to determine whether potentiation of ␣ 1C by DHP agonist and strong depolarization occurs via a common pathway, we have characterized wild-type and mutant ␣ 1C channels and chimeric channels composed of ␣ 1C and ␣ 1A sequence. The channels were fused at their amino termini to green fluorescent protein (GFP), expressed in dysgenic myotubes and examined using whole-cell patch clamp. For an ␣ 1C in which the agonist binding site was mutated (GFP-␣ 1C (TQ → YM)), 10 M Bay K 8644 had no significant effect on whole-cell currents, whereas depolarizationinduced potentiation remained intact. A chimeric channel containing repeat II and the I-II linker of ␣ 1A sequence embedded in L-type background (GFP-CACC) could not support depolarization-induced potentiation but was potentiated by DHP agonist. Channels containing three (CACC), two (CCAA), or no ( ␣ 1A ) repeats of L-type sequence were not potentiated significantly by depolarization, suggesting that depolarization-induced potentiation cannot be localized to any single channel repeat. Interestingly, despite having a relatively low estimated P o comparable to that of ␣ 1C , GFP-CACC was not potentiated by depolarization, indicating that depolarization-induced potentiation must not be dependent solely on a low P o . Our results demonstrate that the mechanisms of DHP agonist-and depolarization-induced potentiation of ␣ 1C are distinct, and that depolarization-induced potentiation may be a global channel property requiring the participation of all four homology repeats.
M A T E R I A L S A N D M E T H O D S

Construction of Chimeric and Mutant ␣ 1 cDNAs
A and C denote sequence derived from ␣ 1A (Mori et al., 1991) or ␣ 1C (Mikami et al., 1989) , respectively. An asterisk indicates a restriction site introduced by PCR. The wild-type clones GFP-␣ 1C and GFP-␣ 1A were produced by fusing the ␣ 1 subunit of either the cardiac L-type channel ( ␣ 1C ) or neuronal P/Q-type channel ( ␣ 1A ) at the amino terminus to GFP as previously described (Grabner et al., 1998) . The GFP tag has been shown not to alter any of the functional properties of the ␣ 1C and ␣ 1A subunits (Grabner et al. 1998 ). The clone GFP-␣ 1C (TQ → YM) was created using overlapping PCR mutagenesis (Horton et al., 1989) to replace two residues in the IIIS5 transmembrane domain of ␣ 1C (Thr 1066 and Gln 1070), which were previously identified as essential components of the DHP binding site (Mitterdorfer et al., 1996; He et al., 1997) , with the corresponding residues of ␣ 1A (Tyr 1393 and Met 1397) . In brief, the SalI*-FspI fragment of ␣ 1C (nt Ϫ 12C-5054C) was subcloned into the SalI and SmaI sites of the pSP72 (Promega) polylinker. Overlapping PCR using GFP-␣ 1C as the template yielded an 816-bp amplification product (nt 2638C-3453C) carrying the point mutations, which was then cut with AflII (nt 2689) and AspI (nt 3385) and ligated into the AflII-AspI restriction sites of the pSP72 subclone. Finally, the SalI*-EcoRV fragment (nt Ϫ 12C-4348C) of the subclone was ligated into GFP-␣ 1C at the corresponding restriction sites to yield the clone GFP-␣ 1C (TQ → YM). The ␣ 1C / ␣ 1A chimera GFP-CACC consisted of repeat II and the I-II linker of ␣ 1A contained an ␣ 1C background (amino acids 1-426C/352-671A/ 740-2171C). To produce GFP-CACC, the SalI*-EcoRV fragment of ␣ 1C (nt Ϫ 12C-4348C) was ligated into the corresponding sites of the plasmid pSP72. PCR mutagenesis was used to amplify a 980-bp product of ␣ 1A sequence, containing the introduced 5 Ј BamHI* and 3 Ј EcoRI* restriction sites at nt 1039 and 2015, respectively. The amplification product was first digested with BamHI, and then partially digested with EcoRI (to avoid cutting an internal EcoRI site), and the resulting fragment was ligated into the corresponding restriction sites of the pSP72/ cardiac subclone. Finally, the SalI*-EcoRV fragment from this subclone was ligated into the SalI*-EcoRV restriction sites of GFP-␣ 1C . The chimera GFP-CCAA was composed of repeats I and II (including the II-III linker) of ␣ 1C and repeats III and IV of ␣ 1A (amino acids 1-920C/1244-2424A). To create GFP-CCAA, the HindIII*-PvuII fragment (nt 3730A-4216A) of chimera AL2 was coligated with the PvuII-BglII fragment of ␣ 1A (nt 4216A-5891A) into the corresponding restriction sites of the plasmid pSP72. Subsequently, the XhoIHindIII* fragment (nt 1395A-2758C) of clone AL5 was ligated into the corresponding restriction sites of the subclone. The entire XhoI-BglII insert (nt 1395A-5891A) of the final subclone was ligated into the corresponding restriction sites of GFP-␣ 1A to produce the intermediate clone GFP-ALC. The SalI*-AvrII fragment (nt Ϫ 12C-759C) of GFP-␣ 1C was coligated with the AvrII-AocI fragment (nt 759C-1752A) of AL5 into the SalI-AocI (5 Ј polylinker-1752A) restriction sites of GFP-ALC, yielding the subclone GFP-C/3A. Finally, the ClaI-AflII fragment (nt 256C-2689C) of ␣ 1C was ligated into the corresponding restriction sites of subclone GFP-C/3A to yield the final chimera GFP-CCAA. The integrity of all channel constructs was confirmed using automated sequence analysis (Macromolecular Resources).
Expression and Electrophysiological Analysis of Channels in Dysgenic Myotubes
1 wk after plating, primary cultures of mouse dysgenic myotubes (Adams and Beam, 1989) , which lack an endogenous ␣ 1S subunit (Knudson et al., 1989) , were microinjected in single nuclei with cDNAs (200-600 ng/l) encoding GFP-tagged ␣ 1 subunits. 36-52 h after injection, expressing myotubes were identified by green fluorescence and used for electrophysiology. Macroscopic Ca 2ϩ currents were measured using the whole-cell patch-clamp method (Hamill et al., 1981) . Whole-cell patch pipettes of borosilicate glass had resistances of 1.5-2.0 M⍀ when filled with an internal solution containing 140 mM cesium aspartate, 10 mM Cs 2 EGTA, 5 mM MgCl 2 , and 10 mM HEPES, pH 7.4 with CsOH. The external bath solution contained 10 mM CaCl 2 , 145 mM TEA-Cl, and 10 mM HEPES, pH 7.4 with TEA-OH, plus 3 M tetrodotoxin. Test currents were obtained by stepping from a holding potential of Ϫ80 to Ϫ30 mV for 1 s (to inactivate endogenous T-type Ca 2ϩ current; Adams et al., 1990) , to Ϫ50 mV for 30-50 ms, to the test potential for 200 ms, to Ϫ50 mV for 125 ms, and back to Ϫ80 mV. Test currents were corrected for linear components of leak and capacitative currents by digitally scaling and subtracting the average of 10 preceding control currents elicited by hyperpolarizing steps (20-40 mV in amplitude) applied from the holding potential. Data were included only for cells in which the maximum voltage error (calculated by the product of peak inward current and compensated series resistance) was Յ10 mV. Except for tail currents, data were sampled at 1 kHz. Tail currents, elicited by repolarizing to Ϫ50 mV for 125 ms, were recorded with fast sampling (10 kHz). Tail-current amplitude (I tail ) was measured 0.5 ms after the onset of the repolarization from the test pulse to Ϫ50 mV. The rate of tail-current decay ( deact ) was measured by fitting tail currents with a single exponential function. Maximal Ca 2ϩ conductance (G max ) and half-maximal activation potential (V 1/2 ) were calculated by fitting peak inward current values with the equation: (1) where I is the peak inward Ca 2ϩ current measured at the test potential (V), V rev is the reversal potential, and k G is a slope factor. The values of G max and V rev were used to calculate normalized conductance as a function of voltage (see Figs. 1 A and 4 C) according to the equation:
Maximum immobilization-resistant charge movement (Q max ) was measured, after the addition of 0.5 mM Cd 2ϩ and 0.1 mM La 3ϩ to the bath, by integration of Q on for a 15-ms test pulse (exponentially rounded with a time constant of 100 s) to ϩ40 mV. Maximum channel P o was calculated from the average, measured values of and according to the equation:
where ϭ -average dysgenic charge (2.5 nC/F; Adams et al., 1990) , ␥ is the single-channel conductance in 10 mM Ca 2ϩ , assumed to be 4 pS for ␣ 1A (Adams et al., 1994) , 5.8 pS for ␣ 1C (Gollasch et al., 1992) , or an average of the two (4.9 pS) for chimeras CACC and CCAA, q is the assumed single-channel gating Noceti et al., 1996) , F is Faraday's constant (96,487 C/mol) and A is Avogadro's number (6.023 ϫ 10 23 e Ϫ /mol).
Several different measures were used to quantify potentiation. For the DHP agonist (Ϯ)Bay K 8644, one measure was the ratio , where the numerator and denominator represent the peak currents elicited by depolarizing test pulses in the presence or absence of drug, respectively.
was usually elicited by a V test of approximately ϩ20-30 mV, and for a V test 20-30 mV more hyperpolarized. Agonist-induced potentiation was also measured by means of the ratios and , where the tail current was produced by repolarizing to Ϫ50 mV from a V test of ϩ40 mV. Depolarization-induced potentiation was quantified by the ratios and , where the numerator and denominator were determined from tail currents produced by repolarization to Ϫ50 mV after a V test of ϩ90-110 mV or ϩ40 mV, respectively.
Statistical Analysis
Statistical significance was assessed using one-way analysis of variance (ANOVA) and SAS software (version 8). All data are presented as mean Ϯ SEM. Fig. 1 A illustrates representative whole-cell Ca 2ϩ currents elicited by depolarizing dysgenic myotubes expressing either GFP-␣ 1C or GFP-␣ 1A to the indicated potentials, followed by repolarization to Ϫ50 mV. Based upon steady-state activation calculated from peak currents during the test depolarizations ( Fig. 1 B) , both channels were fully activated by test pulses to ϩ40 mV and above. Consistent with this, the tail currents for GFP-␣ 1A had a similar amplitude and time course after the depolarizations to either ϩ40 or ϩ60 mV (Fig. 1  A) . However, for GFP-␣ 1C , the tail current after the ϩ60-mV depolarization was larger and decayed more slowly than the tail after the ϩ40-mV step. This behavior is an indication that strong depolarization caused ␣ 1C channels to enter a mode of gating having longer open times and increased P o . Fig. 2 compares currents produced by GFP-␣ 1C and GFP-␣ 1A before and after exposure to 10 M Bay K 8644. For GFP-␣ 1A , application of Bay K 8644 had little effect on either the current elicited by a test depolarization to ϩ20 mV or on the tail current after repolarization (Fig. 2 A) . Likewise, the average, peak current versus voltage relationship for GFP-␣ 1A was not significantly (P Ͼ 0.1) affected by the agonist (Fig. 2 B) . By contrast, Bay K 8644 caused a hyperpolarizing shift in the test potential evoking maximum inward current for GFP-␣ 1C , together with a substantial increase in the magnitude of this current. In addition to affecting the peak current, Bay K 8644 also caused an approximately threefold increase in tail-current amplitude (I tail ) and in the time constant of tail-current deactivation ( deact ) for GFP-␣ 1C (Fig. 2 A and Table I ). Overall, the effects of Bay K 8644 on GFP-␣ 1C tail currents qualitatively resemble those of strong depolarization (compare Figs. 1 A and 2 A). Fig. 3 illustrates a more detailed characterization of tail currents in cells expressing GFP-␣ 1C or GFP-␣ 1A . Fig. 3 A shows the standard protocol for quantifying depolarization-induced potentiation, which was determined as the ratio of either I tail or deact for a tail current after a V test of ϩ90 mV, to the corresponding values for a tail current after a V test of ϩ40 mV. By both measures, GFP-␣ 1C showed substantial depolarization-induced potentiation, whereas GFP-␣ 1A did not ( Fig. 3 A and Table  I ). Fig. 3 B illustrates the dependence of I tail on prior test potentials ranging from Ϫ40 to ϩ80 mV. For GFP-␣ 1A , I tail reached a maximum after a V test of ϩ30 mV, in good agreement with the conductance versus voltage curve calculated from peak currents (Fig. 1 B) . For still stronger depolarizations, I tail became smaller for GFP-␣ 1A , as expected for a channel undergoing voltagedependent inactivation that becomes faster with stronger depolarization. In contrast to GFP-␣ 1A , I tail for GFP-␣ 1C increased monotonically over the entire range of test potentials. This monotonic increase differs from the saturating conductance versus voltage relationship (Fig. 1 B) and is consistent with entry into a potentiated state having high P o . This monotonic voltage dependence also suggests that depolarization-induced potentiation is not dependent upon Ca 2ϩ entry during the prepulse. The application of 10 M Bay K 8644 caused a still further increase in P o , which is indicated by a substantial increase in I tail for GFP-␣ 1C at any given test potential (Fig. 3 B) . In the presence of agonist, I tail was still increased by stronger test depolarizations, up to at least ϩ70 mV. Table I summarizes the effects of DHP agonist and strong depolarization on tail currents for GFP-␣ 1C and GFP-␣ 1A .
R E S U L T S ␣ 1C Is Potentiated by DHP Agonist and Strong Depolarization while ␣ 1A Is Potentiated by Neither
Mutation of T1066 and Q1070 of ␣ 1C Eliminates Agonistbut Not Depolarization-induced Potentiation
The observation that GFP-␣ 1C is potentiated by both agonist and strong depolarization, whereas GFP-␣ 1A is potentiated by neither, raises the possibility that agonist-and depolarization-induced potentiation are linked. As one test of this hypothesis, we created GFP-T A B L E I
Parameters of DHP Agonist-and Depolarization-induced Potentiation
Depolarization-induced potentiation of I tail
0.9-fold Ϯ 0.1
Depolarization-induced potentiation of deact 2.6-fold Ϯ 0.8
2.7-fold Ϯ 0.3 (8)
1.2-fold Ϯ 0.1 (8)
Bay K-induced potentiation of I max 2.7-fold Ϯ 0.2
3.4-fold Ϯ 0.9
1.0-fold Ϯ 0.1
1.1-fold Ϯ 0.1
Bay K-induced activation shift (V 1/2 ; mV)
Ϫ3.0 Ϯ 0.9 (9) Ϫ3.9 Ϯ 1.2
Bay K-induced potentiation of I tail 3.3-fold Ϯ 0.6 (5) 0.9-fold Ϯ 0.1
6.2-fold Ϯ 3.7
1.3-fold Ϯ 0.4
1.2-fold Ϯ 0.1
Bay K-induced potentiation of deact 2.9-fold Ϯ 0.5
3.0-fold Ϯ 0.9
I tail and deact were determined as the amplitude (0.5 ms after repolarization) and time constant of decay (determined by fit of a single exponential) of tail currents produced by repolarization to Ϫ50 mV. Depolarization-induced potentiation was quantified as the ratios ( ) 
, in which two residues of IIIS5 that are critical for the DHP sensitivity of ␣ 1C (Mitterdorfer et al., 1996; He et al., 1997) were converted to the corresponding residues of ␣ 1A . Currents produced by GFP-␣ 1C (TQ→YM) were not affected by the addition of 10 M Bay K 8644 (Fig. 4 A) , whereas depolarizationinduced potentiation was intact (Fig. 4 B) . In particular, tail currents were larger and decayed more slowly after a V test of ϩ90 mV compared with a V test of ϩ40 mV (Fig. 4 B, top) and the tail-current amplitude increased monotonically as a function of test potential (Fig. 4 B, bottom) . On average, GFP-␣ 1C (TQ→YM) was quantitatively similar to GFP-␣ 1C with respect to depolarization-induced potentiation, but was indistinguishable from GFP-␣ 1A in the lack of agonist-induced potentiation (Table I) . Interestingly, mutation of T1066 and Q1070 in the IIIS5 transmembrane segment of ␣ 1C resulted in a decreased steepness, and positive shift, of the steady-state activation curve in comparison to GFP-␣ 1C (Fig. 4 C) , indicating that these residues can affect activation gating. Taken together, the data of Fig. 4 demonstrate that depolarization-induced potentiation still occurs in a mutant ␣ 1C lacking a response to DHP agonist.
Agonist-induced Potentiation Persists in the Absence of Depolarization-induced Potentiation
In an attempt to determine whether a single repeat of ␣ 1C is sufficient to allow depolarization-induced potentiation, we constructed the chimeras GFP-CACC and GFP-CCAA and tested them for agonist-and depolarization-induced potentiation (Fig. 5) . GFP-CACC consists of repeat II and the I-II linker of ␣ 1A in an otherwise ␣ 1C background (Fig. 5 , A and C), and thus contains an intact DHP agonist binding site Hockerman et al., 1997; Ito et al., 1997; Sinnegger et al., 1997) . As shown in Fig. 5 A, 10 M Bay K 8644 potentiated maximum inward current in cells expressing GFP-CACC and caused a leftward shift in the peak current versus voltage relationship. Quantitatively, both effects were similar to those of 10 M Bay K 8644 on GFP-␣ 1C (Table I) . However, this chimera failed to show the large depolarization-induced potentiation characteristic of either GFP-␣ 1C or GFP-␣ 1C (TQ→YM) ( Table I; (A) Tail currents were elicited by depolarization from the holding potential (Ϫ80 mV) to Ϫ30 mV for 1 s (to inactivate endogenous T-type current; Adams et al., 1990 ), a 30-50-ms repolarization to Ϫ50 mV, a 200-ms test depolarization (V test ) to varying potentials, followed by repolarization to Ϫ50 mV. Whole-cell currents are shown for GFP-␣ 1C (top) and GFP-␣ 1A (bottom) for test depolarizations of ϩ40 and ϩ90 mV. Note that for GFP-␣ 1C , the tail current after the V test of ϩ90 mV was larger and decayed more slowly than that after the V test of ϩ40 mV, whereas the tail currents for GFP-␣ 1A differed little for a V test of ϩ40 or ϩ90 mV. The 50-ms time calibration applies to the currents during the test depolarization and the 5-ms calibration to the tail currents at Ϫ50 mV. (B) Relationship of tail-current amplitude (I tail ) at Ϫ50 mV to test pulse potential (V test ) for cells expressing GFP-␣ 1C (circles; n ϭ 5) or GFP-␣ 1A (inverted triangles; n ϭ 7) in the absence (open symbols) or presence (closed symbols) of 10 M Bay K 8644. The amplitude of the tail currents for GFP-␣ 1C grew larger with increasing V test over the entire range of potentials examined, whereas those for GFP-␣ 1A appeared to saturate with peak current.
linker of ␣ 1C fused to repeats III and IV of ␣ 1A . GFP-CCAA lacked both agonist-and depolarization-induced potentiation (Fig. 5 , B and D, and Table I ). Fig. 6 summarizes the effects of strong depolarization and DHP agonist on the constructs GFP-␣ 1C , GFP-␣ 1C (TQ→YM), GFP-CACC, and GFP-␣ 1A . The asterisks indicate a significant (P Ͻ 0.05) difference from onefold (where onefold indicates a lack of potentiation). Fig. 6 demonstrates that depolarization-induced potentiation can persist in the absence of potentiation by agonist (i.e., GFP-␣ 1C (TQ→YM)), and potentiation by agonist can occur in the absence of depolarization-induced potentiation (i.e., GFP-CACC); therefore, the two processes likely occur via distinct mechanisms. Fig. 7 shows that in terms of both amplitude of tail currents (A) and deact (B), the chimeras GFP-CACC and GFP-CCAA, like ␣ 1A , lacked depolarization-induced potentiation. Because GFP-CACC lacked depolarizationinduced potentiation, none of the three cardiac repeats contained in this construct (i.e., I, III, and IV) appears to be sufficient, individually or in concert, to mediate this process. In addition, because GFP-CCAA contains a cardiac repeat II and lacked depolarizationinduced potentiation, a cardiac repeat II does not appear to be sufficient, either alone or in combination with repeat I. In conclusion, no single repeat of ␣ 1C seems to be sufficient for depolarization-induced potentiation, which may instead represent a more global property. Several combinations of multiple repeats are tested by the chimeras examined in this paper, and others cannot be tested because not all possible combinations of repeats of L-type and non-L-type sequence produce functional channels Spaetgens and Zamponi, 1999) . Because potentiation is defined by a shift into a gating mode of substantially increased P o , it seems likely that potentiation could not occur in a channel already having a relatively high P o . Therefore, it is of interest to know whether the lack of depolarization-induced potentiation in GFP-CACC and GFP-CCAA is a consequence of an already high P o . We used Eq. 2 (materials and methods) to estimate P o for GFP-␣ 1C , GFP-CACC, GFP-CCAA, and GFP-␣ 1A from measured values of G max and Q max . The values estimated by this approach for both GFP-␣ 1C and GFP-␣ 1A (Table II) are in reasonable agreement with values determined from single-channel measurements for ␣ 1C (Ͻ0.05; Cachelin et al., 1983; Lew et al., 1991) or ␣ 1A (0.6; Llinas et al., 1989) . Moreover, as shown in Fig. 7 C, the estimated P o for GFP-␣ 1A was about 30-fold higher than for GFP-␣ 1C . The estimated P o for GFP-CCAA was similar to that of GFP-␣ 1A , but estimated P o for GFP-CACC was much closer to that of GFP-␣ 1C (Fig. 7 C and Table II ). The absence of depolarization-induced potentiation for GFP-CACC indicates that a low P o alone is not a sufficient condition for this process to occur. The lack of depolarization-induced potentiation for GFP-CACC is even more striking given that this construct can be strongly potentiated by agonist.
No Single Repeat of ␣ 1C Is Sufficient for Depolarization-induced Potentiation
D I S C U S S I O N
In the present study, we have examined DHP-and depolarization-induced potentiation of L-type Ca 2ϩ channels by expressing GFP-tagged cardiac (␣ 1C ) and neuronal (␣ 1A ) ␣ 1 subunits in dysgenic myotubes. For GFP-␣ 1C , both strong depolarization and agonist (10 M Bay K 8644) caused tail currents to become larger and to decay more slowly, whereas tail currents for GFP-␣ 1A were not affected by either manipulation. Introduction of two point mutations (T1066Y and Q1070M) into GFP-␣ 1C abolished potentiation by agonist without any evident effect on potentiation by depolarization. Conversely, agonist but not depolarization caused potentiation of a chimera of ␣ 1C and ␣ 1A (GFP-CACC). Because depolarization-induced potentiation was absent for both GFP-CACC and the chimera GFP-CCAA, it appears that no single repeat of ␣ 1C can be responsible for this process. GFP-CACC displayed a relatively low estimated P o , quite similar to that of GFP-␣ 1C , whereas the estimated P o for both GFP-CCAA and GFP-␣ 1A was much higher. Therefore, a channel that displays a low P o (and is potentiated by agonist) can fail to be potentiated by depolarization.
Independent Pathways for Potentiation by DHP Agonist and Depolarization
Unitary records of L-type Ca 2ϩ channels have been described as having three modes of gating upon depolarization: mode 0 (null sweeps); mode 1 characterized by brief openings (Ͻ1 ms) in bursts; and mode 2 defined by longer openings and high P o (Hess et al., 1984) . Mode 1 is the predominant mode accessed during moderate depolarizations from the holding potential in the absence of DHP agonist, whereas mode 2 is promoted by the presence of agonist (Hess et al., 1984) . Strong depolarization also promotes long openings of L-type channels in both chromaffin (Hoshi and Smith, 1987) and cardiac cells (Pietrobon and Hess, 1990) . Because we have found that potentiation by either agonist or depolarization can be eliminated without a quantitative reduction in the effect of the other, it appears that these two processes occur via distinct pathways. In addition, we have used a concentration of agonist (10 M Bay K 8644) that is supramaximal (Kokubun and Reu- ter, 1984); therefore, the additional potentiation of tail currents by depolarization in the presence of the agonist also strongly suggests the presence of two independent pathways leading to a potentiated open state. Several other labs have likewise concluded from the additivity of the effects of depolarization and agonist, that these two stimuli cause an increased P o by distinct pathways (Bourinet et al., 1994; Parri and Lansman, 1996) . Moreover, single-channel measurements show both different open times and first latencies depending on whether potentiation is induced by depolarization or agonist (Hoshi and Smith, 1987) . In combination, these data suggest not only that mode 2 gating can be accessed by multiple pathways, but also that mode 2 consists of more than one potentiated open state. Bay K 8644 is well-known to shift activation in the hyperpolarizing direction ( Fig. 2 ; Hess et al., 1984; Sanguinetti et al., 1986) , indicating that it shifts equilibrium towards the open state of the channel. We have shown here that mutation of residues T1066 and Q1070 in the IIIS5 transmembrane domain of ␣ 1C not only ablates the response to agonist, but also shifts the voltage dependence of activation oppositely, in the depolarizing direction. On this basis, one could hypothesize that Bay K 8644 promotes a conformation of these two resi- Figure 7 . Depolarization-induced potentiation cannot be localized to any single channel repeat. Average depolarization-induced potentiation of tail-current amplitude (A), or tail-current deactivation (B) for the indicated constructs. Channel open probability (P o ) for the same constructs (C) was estimated according to Eq. 2 (as described in materials and methods). Values for P o were as follows: ␣ 1C ϭ 0.01, CACC ϭ 0.03, CCAA ϭ 0.14, and ␣ 1A ϭ 0.21. The dashed lines at onefold indicate no potentiation. The number of cells tested in each group ranged from five to eight. Asterisks indicate a significant difference (P Ͻ 0.05) from 1. 
3.0 Ϯ 0.5
2.9 Ϯ 0.4
3.2 Ϯ 0.3
P o 0.007 (5) 0.028 (6) 0.144 (6) 0.212 (7) I max is the peak inward current determined by measuring Ca 2ϩ currents elicited with 200-ms test depolarizations ranging from Ϫ40 to ϩ100 mV. Values for half-maximal activation potential (V 1/2 ) and maximal conductance (G max ) were determined by fitting peak Ca 2ϩ currents according to Eq. 1. Maximum immobilization-resistant charge movement (Q max ) was measured by integration of the "On" gating current for a 15-ms step to ϩ40 mV. Open channel probability (P o ) was estimated using Eq. 2 and measured values of and (as described in materials and methods). All data are presented as mean Ϯ SEM, with numbers in parentheses indicating the number of cells tested.
dues that stabilizes open states of the channel, and mutation of these residues destabilizes this conformation.
Role of Accessory Subunits and of Phosphorylation in Depolarization-induced Potentiation
The accessory ␤ subunit has been shown to influence modal gating of ␣ 1C . In particular, comparison of ␣ 1C expressed with or without the ␤ 2a subunit showed that ␤ 2a increased both open times and the proportion of long openings (Costantin et al., 1998) . ␤ subunits also have been reported to affect depolarization-induced facilitation, which may be mechanistically related to depolarization-induced potentiation (introduction). Specifically, depolarization-induced facilitation was found to occur when ␣ 1C was coexpressed with the ␤ 1 , ␤ 3 , or ␤ 4 subunits (Bourinet et al., 1994; Cens et al., 1998) , but not with ␤ 2a (Cens et al., 1996) , raising the possibility that the ␤ subunit plays a direct role in depolarizationinduced facilitation of ␣ 1C , and perhaps in potentiation as well. However, others have found that depolarizationinduced potentiation of the smooth muscle ␣ 1C occurs in the absence of any ␤ subunit (Kleppisch et al., 1994) . Whatever the exact role of the ␤ subunit, our results demonstrate that depolarization-induced potentiation is strongly influenced by the ␣ 1 subunit itself, because all of the ␣ 1 constructs examined in this study have a conserved "alpha interaction domain" (site of ␤ subunit binding; Pragnell et al., 1994) and were expressed with a common ␤ subunit (␤ 1a , which is endogenous to skeletal muscle; Ruth et al., 1989) . Evidence has been presented that PKA-dependent phosphorylation occurring during depolarizing prepulses is necessary for depolarization-induced facilitation of ␣ 1S (Sculptoreanu et al., 1993b; Johnson et al., 1994) , the cardiac ␣ 1C (Sculptoreanu et al., 1993a) , and the neuronal ␣ 1C (Sculptoreanu et al., 1995) . Evidence also has been presented that phosphorylation during depolarization is not involved in depolarizationinduced facilitation of the neuronal ␣ 1C , although basal phosphorylation may be required (Bourinet et al., 1994) . If phosphorylation is required (either basal or voltage-dependent), then it seems unlikely to involve phosphorylation of ␣ 1C directly because truncation of the consensus PKA sites (Gao et al., 1997) of the ␣ 1C carboxyl tail does not eliminate depolarization-induced facilitation (Cens et al., 1998) . Consistent with this result, we found that depolarization-induced potentiation does not occur for GFP-CACC even though it contains all the consensus PKA sites of ␣ 1C .
Structural Determinants of Depolarization-induced Potentiation and Low P o
As discussed above, brief openings predominate during activation of ␣ 1C by modest depolarizations applied from a negative holding potential (mode 1 gating).
The conformational changes responsible for activation of these brief openings occur rapidly (macroscopic activation occurs with a time constant of several ms at ϩ30 mV; Tanabe et al., 1991) . Depolarization-induced entry into mode 2 occurs on a significantly slower time scale (with a time constant of several hundred ms at ϩ30 mV) and over a much more positive voltage range (Pietrobon and Hess, 1990) . Despite these differences, depolarization-induced potentiation resembles mode 1 activation in being strongly voltage-dependent: based on two-state Boltzmann fits, the effective gating charge is 2.5 for depolarization-induced potentiation and 3.2 for mode 1 activation (Pietrobon and Hess, 1990) . Thus, the question arises as to the identity of the voltage sensor for depolarization-induced potentiation. One possibility is that, after undergoing the relatively rapid movements leading to mode 1 openings, the S4 segments can undergo subsequent, slower movements in response to still stronger depolarization. It is equally possible that structures other than S4 serve as voltage sensors for depolarization-induced potentiation. Because we found that neither GFP-CACC nor GFP-CCAA undergo depolarization-induced potentiation, it seems unlikely that the voltage-sensing structures for depolarization-induced potentiation are localized within a single repeat. Rather, depolarization-induced potentiation of ␣ 1C appears to require large movements of charge distributed throughout the protein.
L-type channels like ␣ 1S and ␣ 1C differ from ␣ 1A channels in that the L-type channels display agonist-and depolarization-induced potentiation, and also have a much lower P o , raising the possibility that the structural determinants of potentiation and low P o reside in similar structures. However, the chimera GFP-CACC had a relatively low P o , yet did not display significant depolarization-induced potentiation. Because the chimera GFP-CCAA displayed a high P o , the amino-terminal half of ␣ 1C (repeats I and II) does not appear to be an important determinant of low P o ; instead, structural requirements for low P o may reside in the carboxyl half of the protein. Certainly, it is attractive to hypothesize that repeats III and IV are important for the intrinsic, low P o of L-type channels since these same two repeats play an essential role in agonist binding, which increases P o . A role for the carboxyl tail in determining P o is suggested by previous work showing that P o of ␣ 1C is markedly increased by partial truncation of the carboxyl tail (Wei et al., 1994) .
As stated earlier, the P o of the L-type channels containing ␣ 1C (Ͻ0.05; Cachelin et al., 1983; Lew et al., 1991) is much lower than that of the neuronal channels containing ␣ 1A (0.6; Llinas et al., 1989) or ␣ 1B (0.5; Delcour and Tsien, 1993 Rittenhouse and Hess, 1994) , the produc-tion of an equivalent macroscopic current would require a much higher density of the L-type channels. A primary role of L-type Ca 2ϩ channels in muscle is to regulate Ca 2ϩ movements through ryanodine receptors. For this control to be relatively tight, it may be useful to have an ‫1:1ف‬ correspondence between the plasmalemmal L-type channels and the intracellular ryanodine receptors. Perhaps this correspondence is best served by a relatively high density of low P o channels. Conversely, a high P o and relatively low channel density would be advantageous when it is critical that a cellular response be triggered by the activation of only a few channels. Important goals for future work will be to better define the structures determining the differences in P o between ␣ 1C and neuronal channels like ␣ 1A and ␣ 1B , and to identify the conformational rearrangements that occur during potentiation of L-type channels. 
